Tissue Microarray Technique in Evaluation of Proliferative Activity in Invasive Ductal Breast Cancer

被引:0
|
作者
Kobierzycki, Christopher [1 ]
Pula, Bartosz [1 ]
Wojnar, Andrzej [2 ]
Podhorska-Okolow, Marzena [1 ]
Dziegiel, Piotr [1 ,3 ,4 ]
机构
[1] Med Univ, Dept Histol & Embryol, PL-50368 Wroclaw, Poland
[2] Lower Silesian Oncol Ctr, Wroclaw, Poland
[3] Med Univ, Dept Histol & Embryol, Poznan, Poland
[4] Univ Wroclaw, Sch Phys Educ, Dept Physiotheraphy, Wroclaw, Poland
关键词
Tissue microarray; TMA; breast cancer; Ki-67; MCM-2; KI-67; ANTIGEN-EXPRESSION; NEEDLE-BIOPSY SPECIMENS; DNA-REPLICATION; MCM PROTEINS; PROGNOSTIC-SIGNIFICANCE; LUNG-CANCER; METALLOTHIONEIN; CELLS; BLOCK; VALIDATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Investigation of the relationship between expression of Ki-67 antigen and Minichromosome maintenance 2 (MCM-2) protein by using an immunohistochemical study on whole sections (WS) and sections of invasive ductal breast cancer (IDC) obtained in the tissue microarray (TMA) technique. Materials and Methods: Material consisted of 51 archival paraffin blocks of IDC. Tissue microarrays were composed of 0.6 mm core punches. Reactions were peformed using specific antibodies (anti-Ki-67 and anti-MCM-2). Intensity of the marker expression was evaluated using computer-assisted image analysis. For statistical purposes, three different tests were used. Results: Spearman rank correlation revealed a strong positive correlation between expression of tested markers: Ki-67 (TMA) vs. Ki-67 (WS) (r=0.91, p<0.05) and MCM-2 (TMA) vs. MCM-2 (WS) (r=0.87, p<0.05). Mann Whitney U-test showed no significant differences between the two markers in both analysed techniques. Moreover, the Bland-Altman plot demonstrated a low level of bias between the analysed methods. Conclusion: This study shows that TMA could have a great potential in evaluation of proliferative activity in IDC and that MCM-2 protein might he a specific and sensitive marker of cell proliferation.
引用
收藏
页码:773 / 777
页数:5
相关论文
共 50 条
  • [41] CTCF gene mutations in invasive ductal breast cancer
    Aulmann, S
    Bläker, H
    Penzel, R
    Rieker, RJ
    Otto, HF
    Sinn, HP
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (03) : 347 - 352
  • [42] Coexistence of phylloides tumour and invasive ductal cancer in the breast
    Bozkurt, H.
    Karakaya, I. B.
    Aktas, E.
    Irkorucu, O.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2019, 22 (08) : 1169 - 1171
  • [43] Invasive ductal breast cancer metastatic to the sigmoid colon
    Xiao-cong Zhou
    Hong Zhou
    Ying-hai Ye
    Xiu-feng Zhang
    Yi Jiang
    World Journal of Surgical Oncology, 10
  • [44] Invasive breast cancer following ductal and lobular carcinoma in situ of the breast
    Levi, F
    Randimbison, L
    Te, VC
    La Vecchia, C
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (05) : 820 - 823
  • [45] THE IMPORTANCE OF DUCTAL EVALUATION AND BIOMARKERS IN DUCTAL FLUID IN BREAST CANCER
    Guer, A. Serhat
    Bonaventura, Marguerite
    Uenal, Buelent
    Soran, Atilla
    JOURNAL OF BREAST HEALTH, 2008, 4 (03): : 138 - 142
  • [46] Leptin:: A proliferative factor for breast cancer?: Study on human ductal carcinoma
    Caldefie-Chézet, F
    Damez, M
    de Latour, M
    Konska, G
    Mishellani, F
    Fusillier, C
    Guerry, M
    Penault-Llorca, F
    Guillot, J
    Vasson, MP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 334 (03) : 737 - 741
  • [47] Tissue Microarray Is a Reliable Tool for the Evaluation of HER2 Amplification in Breast Cancer
    Furrer, Daniela
    Jacob, Simon
    Caron, Chantal
    Sanschagrin, Francois
    Provencher, Louise
    Diorio, Caroline
    ANTICANCER RESEARCH, 2016, 36 (09) : 4661 - 4666
  • [48] Contralateral breast cancer in patients with ductal carcinoma in situ and invasive breast cancer in the Netherlands
    Giardiello, D.
    Kramer, I.
    Hooning, M. J.
    Hauptmann, M.
    Lips, E.
    Sawley, E.
    Thompson, A.
    de Munck, L.
    Siesling, S.
    Wesseling, J.
    Steyerberg, E. W.
    Schmidt, M. K.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S12 - S12
  • [49] Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
    Daniele Giardiello
    Iris Kramer
    Maartje J. Hooning
    Michael Hauptmann
    Esther H. Lips
    Elinor Sawyer
    Alastair M. Thompson
    Linda de Munck
    Sabine Siesling
    Jelle Wesseling
    Ewout W. Steyerberg
    Marjanka K. Schmidt
    npj Breast Cancer, 6
  • [50] Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
    Giardiello, Daniele
    Kramer, Iris
    Hooning, Maartje J.
    Hauptmann, Michael
    Lips, Esther H.
    Sawyer, Elinor
    Thompson, Alastair M.
    de Munck, Linda
    Siesling, Sabine
    Wesseling, Jelle
    Steyerberg, Ewout W.
    Schmidt, Marjanka K.
    NPJ BREAST CANCER, 2020, 6 (01)